Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

https://www.chemsilico.com/web/image/product.template/46632/image_1920?unique=1dbb3eb
Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00

Not Available For Sale

    This combination does not exist.

    Terms and Conditions
    30-day money-back guarantee
    Shipping: 2-3 Business Days


    Website URL: /shop/gma-tnfrsf9-gentaur-urelumab-anti-tnfrsf9-cd137-antibody-46632
    Internal Reference: GMA-TNFRSF9

    How Does Human Metapneumovirus (hMPV) Compare to COVID-19?